Newsfeeds - Spark Newswire

1 minute read

Immunic FY EPS $(3.78) Misses $(2.90) Estimate; $116.4M In Cash, Cash Equivalents and Investments Expected to Fund Immunic Into Q4 Of 2024

Today, 4:09 AM

Immunic (NASDAQ:IMUX) reported quarterly losses of $(3.78) per share which missed the analyst consensus estimate of $(2.90) by 30.34 percent. This is a 3.82 percent increase over losses of $(3.93) per share from the same

IMUX

17 minute read

Earnings

Earnings Scheduled For February 23, 2023

By Benzinga Insights

Today, 4:09 AM

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

AAOI

1 minute read

Wedbush Assumes Immunic at Outperform, Announces Price Target of $5

By Benzinga Newsdesk

Today, 4:09 AM

Wedbush analyst Andreas Argyrides assumes Immunic (NASDAQ:IMUX) with a Outperform rating and announces Price Target of $5.

IMUX

13 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 4:09 AM

Wednesday saw 219 companies set new 52-week lows.

$APE

11 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 4:09 AM

Tuesday's session saw 167 companies set new 52-week lows.

ACHL

2 minute read

BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying

By Lisa Levin

Today, 4:09 AM

The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BARK

1 minute read

Immunic Reports New Data From Phase 2 EMPhASIS Trial Of Vidofludimus Calcium In Relapsing-Remitting Multiple Sclerosis Supporting The Drug’s Neuroprotective Potential

By Benzinga Newsdesk

Today, 4:09 AM

– Data Show Encouraging Signals for Vidofludimus Calcium for Preventing or Delaying Confirmed Disability Worsening – – Virtual Multiple Sclerosis R&D Day to be Held Today, November 17,

IMUX